Uncategorized
VIDEO: ProQR develops RNA treatments aimed at rare diseases
VANCOUVER, British Columbia ― Daniel de Boer, CEO of ProQR, discusses the company’s ophthalmology pipeline, including QR-110 for Leber’s congenital amaurosis type 10 presented during the Foundation Fighting Blindness Emerging Science Showcase at OIS Retina.